The Association of Different Levels of Physical Activity on Postoperative Pulmonary Complications in Patients Undergoing Thoracoscopic Lung Resection Surgery

March 10, 2024 updated by: Changping Gu, Qianfoshan Hospital

The Association of Different Levels of Physical Activity on Postoperative Pulmonary Complications in Patients Undergoing Thoracoscopic Lung Resection Surgery: A Prospective Cohort Study

This study aimed to predict different physical activity (PA) levels in patients undergoing thoracoscopic lung resection surgery (LRS) using the International Physical Activity Questionnaire (IPAQ) and investigate the association between the PA levels and the incidence of postoperative pulmonary complications (PPCs). The patients were classified into the high-level and low-level PA groups based on the IPAQ scores. The incidence of PPCs within postoperative 5 days, number of PPCs, the incidence of postoperative adverse events (PAEs) within postoperative 5 days, extubation time, length of hospital stay (LOS), unplanned admission to the intensive care unit (ICU), and the mortality 1-month postoperatively were recorded. Arterial blood samples were collected before induction of anesthesia and 1 hour postoperatively, and the supernatants were centrifuged for cytokine analysis. Binomial logistic analysis was performed to determine the relationship between predefined variables and PPCs. Receiver operating characteristic (ROC) curve analysis was performed to identify independent risk factors, and the area under the curve (AUC) was calculated.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

245

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shandong
      • Jinan, Shandong, China, 250014
        • China, Shandong Qianfoshan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients aged 18~80 years undergoing elective thoracoscopic lung resection surgery under general anesthesia

Description

Inclusion Criteria:

  1. Patients older than 18 years and younger than 80 years;
  2. Patients scheduled to accept elective thoracic surgery under general anesthesia;
  3. Patients of American Society of Anesthesiologists (ASA) Ⅱ~Ⅲ level grade;
  4. Patients signed the informed consent form for the clinical study.

Exclusion Criteria:

  1. Patients with moderate or severe chronic obstructive pulmonary disease (GOLD Grade III or IV level grade);
  2. Patients with severe or uncontrolled bronchial asthma;
  3. Patients with severe neuromuscular disease or thoracic malformation;
  4. Patients with severe heart disease (New York Heart Association Class III or IV level grade or acute coronary syndrome or persistent ventricular arrhythmia);
  5. Patients with cognitive dysfunction;
  6. Patients who have participated in other clinical trials within the previous 30 days;
  7. Patients with coagulation dysfunction;
  8. Patients who received radiotherapy or chemotherapy within 2 months before surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Adequate physical activity group
At least 600 met-minutes /week for five or more days of walking, moderate and strenuous physical activity per week.
Insufficient physical activity group
Less than 600 met-minutes /week for five or more days of walking, moderate and strenuous physical activity per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of pulmonary complications
Time Frame: Within five days after surgery
  1. Respiratory Infection
  2. Respiratory Failure
  3. Pleural Effusion
  4. Atelectasis
  5. Pneumothorax
  6. Bronchospasm
  7. Aspiration pneumonitis
Within five days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extubation time
Time Frame: The time from the end of surgery to the removal of the endotracheal intubation.
The time from the end of surgery to the removal of the endotracheal intubation.
Postoperative length of stay
Time Frame: During the study procedure
During the study procedure
The number of postoperative pulmonary complications
Time Frame: Within five days after the surgery
Within five days after the surgery
Mortality 1 month after surgery
Time Frame: Within 1 month of the end of surgery
Within 1 month of the end of surgery
The arterial levels of inflammatory markers
Time Frame: before induction of anesthesia(T0),1.5 hours after the beginning of surgery(T2),3 hours after the beginning of surgery(T3)and 1 hour after the end of surgery(T4).
interleukin-6(IL-6), interleukin-8(IL-8), tumor necrosis factor-α(TNF-α)
before induction of anesthesia(T0),1.5 hours after the beginning of surgery(T2),3 hours after the beginning of surgery(T3)and 1 hour after the end of surgery(T4).
Incidence of postoperative adverse events
Time Frame: Within five days after operation
  1. arrhythmia
  2. acute cardiovascular disease (myocardial infarction, heart failure)
  3. acute cerebrovascular disease (cerebral infarction, cerebral hemorrhage, TIA)
  4. acute postoperative psychiatric disorder (delirium,somnolence,coma)
  5. shock
Within five days after operation
Unplanned admission to the ICU
Time Frame: Within five days after operation
Within five days after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Changping Gu, doctor, Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

November 30, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

April 25, 2022

First Submitted That Met QC Criteria

May 27, 2022

First Posted (Actual)

June 2, 2022

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 10, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pulmonary Complications

Subscribe